What's Happening?
The femtech market is experiencing significant growth, driven by advancements in hormone-aware sleep tracking devices. Companies like Natural Cycles and Oura are leading the charge by integrating cycle-informed sleep tracking into their wearable devices. This
shift moves femtech from reproductive care to hormonal health management, offering personalized insights beyond simple sleep analytics. The market is projected to grow from $52.74 billion in 2025 to $155.81 billion by 2035, with a compound annual growth rate of 11.4%. The digital segment alone generated $4.36 billion in 2025, highlighting the increasing demand for personalized health insights. Natural Cycles, founded by physicists Dr. Elina Berglund Scherwitzl and Dr. Raoul Scherwitzl, has expanded its offerings to include postpartum and perimenopause tracking, while Oura has released a proprietary women's health AI model. These developments reflect a broader shift in the perception of sleep as a beauty, recovery, and longevity category.
Why It's Important?
The growth of the femtech market and the integration of hormone-aware technologies into sleep tracking devices have significant implications for women's health. By providing personalized insights into hormonal changes, these devices offer a more comprehensive understanding of sleep patterns and their impact on overall health. This shift from passive tracking to active intervention can lead to improved health outcomes and preventive care. The market's expansion also highlights the increasing demand for personalized health solutions, which can drive innovation and investment in the sector. As more companies enter the market, consumers can expect a wider range of options tailored to their specific needs, potentially improving access to health care and empowering women to take control of their health.
What's Next?
The femtech market is poised for continued growth, with companies likely to expand their offerings to include more personalized health insights. As hormone-aware technologies become the expected standard, consumers can anticipate further integration of these features into wearable devices. This trend may lead to increased competition among companies, driving innovation and potentially lowering costs for consumers. Additionally, the convergence of menstrual cycle tracking and sleep tech signals a broader shift in the perception of sleep as a critical component of health and wellness. As the market evolves, stakeholders, including health care providers and policymakers, may need to address regulatory and ethical considerations related to data privacy and the use of AI in health care.
